Cost-effectiveness analysis of prostaglandin E2 gel for the induction of labour at term

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 6, 2011, Pages 726-734

  Petrou, S ^a   Taher, S E ^b   Abangma, G ^c   Eddama, O ^c   Bennett, P ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cost effectiveness analysis; induction of labour; prostaglandin; randomised controlled trial

Indexed keywords

PLACEBO; PROSTAGLANDIN E2;

ARTICLE; BOOTSTRAPPING; CEPHALIC PRESENTATION; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DELIVERY; DRUG COST; DRUG DOSAGE FORM COMPARISON; ECONOMIC EVALUATION; GEL; GESTATIONAL AGE; HEALTH CARE COST; LABOR COMPLICATION; LABOR INDUCTION; LENGTH OF STAY; MATERNITY WARD; NATIONAL HEALTH SERVICE; NEWBORN CARE; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; POSITION; PREGNANT WOMAN; PRIORITY JOURNAL; PROBABILITY; TEACHING HOSPITAL; UNITED KINGDOM;

EID: 79954480366     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.02902.x     Document Type: Article

References (22)

1. National Collaborating Centre for Women's and Children's Health. Induction of Labour. Clinical Guideline. London, UK: NICE press, 2008.
2. Hofmeyr GJ, Alfirevic Z, Kelly AJ, Kavanagh J, Thomas J, Brocklehurst P, et al., Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database Syst Rev 2000; Art. No.: CD002074. DOI:.
3. Kelly AJ, Kavanagh J, Thomas J,. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2003; Art. No.: CD003101. DOI:.
4. Taher SE, Inder JW, Soltan SA, Eliahoo J, Edmonds DK, Bennett P,. Prostaglandin E2 vaginal gel or tablets for the induction of labour at term: a randomised controlled trial. BJOG 2011: DOI:.
5. Calder AA, Embrey MP, Hillier K,. Extra-amniotic prostaglandin E2 for the induction of labour at term. J Obstet Gynaecol Br Commonw 1974; 81: 39-46.
6. National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London, UK: NICE, 2008. []. Last accessed 2 December 2010.
7. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL,. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford, UK: Oxford University Press, 2005.
8. Department of Health. NHS Reference Costs 2007. London, UK: Department of Health, 2007.
9. Allen C, Beecham J,. Costing services: ideals and reality. In:, Netten A, Beecham J, editors. Costing Community Care: Theory and Practice. Aldershot, UK: Ashgate Publishing Ltd; 1993. pp. 25-42.
10. British National Formulary (BNF). BNF for Children. London, UK: BNF, 2007.
11. Barber JA, Thompson SG,. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19: 3219-36.
12. Black WC,. The cost-effectiveness plane: a graphical representation of cost-effectiveness. Med Decis Making 1990; 10: 212-5.
13. Stinnett AA, Mullahy J,. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998; 18 (Suppl 2): S68-80. (Pubitemid 28175944)
14. Gray A, Clarke P, Wolstenholme J, Wordsworth S,. Applied Methods of Cost-Effectiveness Analysis in Health Care. Oxford: Oxford University Press, 2010.
15. Drummond MF, Jefferson TO,. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313: 275-83. (Pubitemid 26254740)
16. Redshaw M, Rowe R, Hockley C, Brocklehurst P,. Recorded Delivery: A National Survey of Women's Experience of Maternity Care, 2006. Oxford: National Perinatal Epidemiology Unit: University of Oxford, 2007.
17. Eddama O, Petrou S, Schroeder L, Bollapragada SS, MacKenzie F, Norrie J, et al., The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG 2009; 116: 1196-203.
18. Vijgen SM, Koopmans CM, Opmeer BC, Groen H, Bijlenga D, Aarnoudse JG, et al., An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). BJOG 2010; 117: 1577-85.
19. Taylor SJ, Armour CL,. Cost implications in the management of induction of labour. Pharmacoeconomics 1997; 12: 547-54. (Pubitemid 27471143)
20. Longworth L, Ratcliffe J, Boulton M,. Investigating women's preferences for intrapartum care: home versus hospital births. Health Soc Care Community 2001; 9: 404-13. (Pubitemid 33696686)
21. Hundley V, Ryan M, Graham W,. Assessing women's preferences for intrapartum care. Birth 2001; 28: 254-63.
22. Taylor S, Armour C,. Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modelling. Pharmacoeconomics 2003; 21: 721-35. (Pubitemid 36920637)